BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86%
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note

BRAIN Biotech AG
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BRAIN Biotech AG
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Depreciation & Amortization
€7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Depreciation & Amortization
€439m
CAGR 3-Years
5%
CAGR 5-Years
-5%
CAGR 10-Years
-3%
Evonik Industries AG
XETRA:EVK
Depreciation & Amortization
€1B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
5%
Covestro AG
XETRA:1COV
Depreciation & Amortization
€884m
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Depreciation & Amortization
€25.9m
CAGR 3-Years
4%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Depreciation & Amortization
€312.7m
CAGR 3-Years
8%
CAGR 5-Years
0%
CAGR 10-Years
N/A
No Stocks Found

BRAIN Biotech AG
Glance View

Market Cap
75.2m EUR
Industry
Chemicals

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

BNN Intrinsic Value
5.16 EUR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is BRAIN Biotech AG's Depreciation & Amortization?
Depreciation & Amortization
7m EUR

Based on the financial report for Jun 30, 2024, BRAIN Biotech AG's Depreciation & Amortization amounts to 7m EUR.

Back to Top